Universal View
Ophthalmic medical devices for non-surgical vision correction.
| Date | Investors | Amount | Round |
|---|---|---|---|
| investor investor investor | €0.0 | round | |
| investor | €0.0 | round | |
| investor investor | €0.0 | round | |
| investor | €0.0 | round | |
N/A | Acquisition | ||
| Total Funding | 000k | ||
Universal View Co., Ltd. is a development-stage venture company specializing in ophthalmic medical devices. The firm's primary product is the "Breath O Correct," an orthokeratology lens developed for the Japanese market. This contact lens is worn during sleep to correct the cornea's shape, allowing users to have clear vision during the day without glasses or surgery.
The company was founded by Taro Suzuki and operates in the MedTech sector. It has formed strategic partnerships to expand its market reach. The product, which received medical device approval from the Ministry of Health, Labour and Welfare in 2012, was co-developed with material from Toray Industries, Inc. and is distributed in Japan through a network that includes SEED Co., Ltd., which became the principal shareholder in 2018. In March 2021, SEED acquired all remaining shares from INCJ, making Universal View a subsidiary.
The business model focuses on developing and marketing these specialized lenses to a network of over 300 ophthalmology professionals and eye care clinics across Japan. Universal View aims to enhance the quality of life for patients by providing a non-invasive vision correction alternative.
Keywords: orthokeratology, ophthalmic devices, vision correction, medical devices, MedTech, non-surgical treatment, contact lenses, eye care, visual acuity, ophthalmology, healthcare technology, Japanese market, corneal reshaping, myopia control, Toray Industries, SEED Co. Ltd., Taro Suzuki, INCJ.